Corrigendum to "Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years" [Vaccine 35 (2017) 1254-1258]

Vaccine. 2017 May 25;35(23):3152. doi: 10.1016/j.vaccine.2017.04.061. Epub 2017 Apr 27.

Authors

Roger Baxter¹, Abigail Eaton¹, John Hansen², Laurie Aukes¹, Herve Caspard³, Christopher S Ambrose³

Affiliations

¹ Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, Ordway Building, 16th Floor, Oakland, CA 94612, United States.
² Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, Ordway Building, 16th Floor, Oakland, CA 94612, United States. Electronic address: john.hansen@kp.org.
³ AstraZeneca, One MedImmune Way, Gaithersburg, MD 20878, United States.

PMID: 28457674
DOI: 10.1016/j.vaccine.2017.04.061

No abstract available

Publication types

Published Erratum